About Neurovate
Founded in 1996, Neurovate Biotechnologies has remained at the forefront of neurochemical research, pioneering interventions in cognition, emotional regulation, and behavioral optimization.
We collaborate with defense, educational, and private sectors to create tailored pharmacological solutions for the most complex behavioral conditions.
Our core facilities operate under full clinical compliance, with all protocols approved through Tier-3 ethical review under Section 4.2 of the Human Testing Act (HTA).
